A monitoring list for oral anticoagulation case management in primary care;Eine Monitoring-Liste für ein hausärztliches Case Management bei oraler Antikoagulation

Zeitschrift fur Allgemeinmedizin

Volumn 89, Issue 4, 2013, Pages 165-171

  Ulrich, Lisa Rebekka ^a   Petersen, Juliana J ^a   Mergenthal, Karola ^a   Roehl, Ina ^a   Rauck, Sandra ^a   Erler, Antje ^a   Kemperdick, Birgit ^a   Schulz Rothe, Sylvia ^a   Gerlach, Ferdinand M ^a   Siebenhofer, Andrea ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Case management; Chronic illness; Family medicine; Oral anticoagulation

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MONITORING; EVIDENCE BASED DENTISTRY; MEDICAL RESEARCH; NONHUMAN; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION;

EID: 84886511799     PISSN: 09376801     EISSN: 14399229     Source Type: Journal    
DOI: 10.3238/zfa.2013.0165-0171     Document Type: Article

References (20)

1. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schünemann HJ. Executive summary antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines. Chest 2012; 141 (2 suppl): 7S-47S
2. Hua TD, Vormfelde SV, Abed MA, Schneider-Rudt H, Sobotta P, Chenot JF. Orale Antikoagulation in der Hausarztpraxis. Z Allg Med 2010; 10: 382-389
3. Leitliniengruppe Hessen. Hausärztliche Leitlinie Antikoagulation: Antikoagulation mit Vitamin-K-Antagonisten. Version 1.00; Juli 2006. Verfügbar unter: http://www. pmvforschungsgruppe.de/pdf/03- publikationen/antikoagulation-ll.pdf (letzter Zugriff am 27.11 12)
4. Saal K, Hoffmann B, Blauth E, et al. Analyse des Behandlungsprozess bei der oralen Antikoagulationstherapie zur Identifikation von Sicherheitsproblemen in der hausärztlichen Versorgung. Z Allg Med 2009; 85: 148-155
5. Ufer M. Comparative efficacy and safety of the novel oral anticoagulants dabigatran, rivaroxaban and apixaban in preclinical and clinical development. Thromb Haemost 2010; 103: 572-585
6. Glasziou P, Irwig L, Mant D. Monitoring in chronic disease: a rational approach. BMJ 2005; 330:644-648 (Pubitemid 40444763)
7. Gensichen J, Jaeger C, Peitz M, et al. Health care assistants in primary care depression management: role perception, burdening factors, and disease conception. Ann Fam Med 2009; 7: 513-519
8. Rosemann T, Joos S, Laux G, Gensichen J, Szecsenyi J. Case management of arthritis patients in primary care: a cluster- randomized controlled trial. Arthritis Rheum 2007; 57: 1390-1397 (Pubitemid 350308835)
9. Peters-Klimm F, Campbell S, Hermann K, et al. Case management for patients with chronic systolic heart failure in primary care: The HICMan exploratory randomised controlled trial. Trials 2010; 11: 56
10. Siebenhofer A, Ulrich LR, Mergenthal K, et al. Primary care management for optimized antithrombotic treatment [PICANT]: study protocol for a clusterrandomized controlled trial. Implement Sci 2012; 7: 79
11. Gensichen J, Peitz M, Torge M, et al. Die "Depressions-Monitoring- Liste (De- MoL)" mit integriertem PHQ-D: Rationale und Entwicklung eines Instruments für das hausärztliche Case Management bei Depression. Z Arztl Fortbild Qualitatssich 2006; 100: 375-382 (Pubitemid 44186756)
12. Freund T, Baldauf A, Muth C, Gensichen J, Szecsenyi J, Peters-Klimm F. Praxisbasiertes Hausbesuchs- und Telefonmonitoring von Patienten mit Herzinsuffizienz: Rationale, Design und praktische Anwendung der Monitoringslisten in der HICMan-Studie. Z Arztl Fortbild Qualitatssich 2011; 105: 434-445
13. Camm AJ, Lip GYH, Caterina R de, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Eur Heart J 2012; 33: 2719-2747
14. Sawicki PT. A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. JAMA 1999; 281:145-150 (Pubitemid 29045346)
15. Siebenhofer A, Rakovac I, Kleespies C, Piso B, Didjurgeit U. Self-management of oral anticoagulation in the elderly: Rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thromb Haemost 2007; 97: 408-416 (Pubitemid 46437803)
16. Arzneimittelkommission der deutschen Ärzteschaft (AkdÄ) - September 2012. Leitfaden der AkdÄ: Orale Antikoagulation bei nicht valvulärem Vorhofflimmern. http://www.akdae.de/ Arzneimitteltherapie/TE/LF/ PDF/ OAKVHF.pdf. (letzter Zugriff am 19.11.12)
17. Gensichen J, Guethlin C, Sarmand N, et al. Patients' perspectives on depression case management in general practice - a qualitative study. Patient Educ Couns 2012; 86: 114-119
18. Garcia DA, Witt DM, Hylek E, et al. Delivery of Optimized Anticoagulant Therapy: Consensus Statement from the Anticoagulation Forum. Ann Pharmacother 2008; 42: 979-988
19. Canadian Agency for Drugs and Technologies in Health. Common drug review. CEDAC final recommendation: Dabigatran etexilate; June 2011. http://www.cadth.ca/media/cdr/ complete/cdr-complete-Pradax- June-27-11.pdf (letzter Zugriff am 20.12.12)
20. The Swedish Council on Health Technology Assessment (SBU). Dabigatran to prevent stroke in patients with atrial fibrillation. SBU Alert Report no 2011-04. http://www.sbu.se/upload/Publikationer/ Content1/1/Dabigatran-Prevent- Stroke-Patients-With-Atrial-Fibrillation-201104.pdf (letzter Zugriff am 20.12.12)